Results 181 to 190 of about 381,163 (319)
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics
Abstract Before the controversial approval of humanized monoclonal antibody lecanemab, which binds to the soluble amyloid‐β protofibrils, all the treatments available earlier, for Alzheimer's disease (AD) were symptomatic. The researchers are still struggling to find a breakthrough in AD therapeutic medicine, which is partially attributable to lack in ...
Sharif Arar+2 more
wiley +1 more source
Associations between apolipoprotein B and bone mineral density: a population-based study. [PDF]
Zhao X+7 more
europepmc +1 more source
Chicken Oocytes and Fibroblasts Express Different Apolipoproteins-B-Specific Receptors
Kôzô Hayashi+2 more
openalex +1 more source
The Surface-Exposed, Trypsin-Accessible Segments of Apolipoprotein B in the Low-Density Lipoprotein of Human Serum [PDF]
M. John Chapman+6 more
openalex +1 more source
Abstract Lecanemab is a humanized immunoglobulin G1 monoclonal antibody that selectively binds to soluble Aβ aggregate species, while demonstrating low affinity for Aβ monomer. This article describes the population pharmacokinetic (PK) and PK/pharmacodynamic (PD) analyses for amyloid plaques, as measured using positron emission tomography (PET), and ...
Seiichi Hayato+8 more
wiley +1 more source
Lipoprotein [a] (Lp[a]) contains equimolar amounts of apoB-100 and apolipoprotein [a] (apo[a]). Both proteins are amenable to degradation in vivo by mechanisms yet to be clearly defined.
Celina Edelstein+3 more
doaj
Is it time to measure apolipoprotein B? [PDF]
A D Sniderman, J Silberberg
openaire +3 more sources
Simultaneous quantification by double rocket immunoelectrophoresis of apolipoproteins A-I and B in blood spotted on filter paper. [PDF]
S. Mičić+4 more
openalex +1 more source
Abstract Despite considerable investment into potential therapeutic approaches for Alzheimer's disease (AD), currently approved treatment options are limited. Predictive modeling using quantitative systems pharmacology (QSP) can be used to guide the design of clinical trials in AD.
Vidya Ramakrishnan+15 more
wiley +1 more source
Comprehensive analysis of cortical astrocyte gene expression across the lifespan. Profiling dynamic changes of key astrocyte genes reveals functional shifts. Astrocytes contribute to gene‐length‐dependent transcription decline in the aging brain. ABSTRACT Astrocytes are the most abundant glial cell type in the central nervous system (CNS).
Xiaoran Wei+2 more
wiley +1 more source